Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme
- PMID: 21521431
- PMCID: PMC5060635
- DOI: 10.1111/j.1369-7625.2011.00686.x
Assessing the usability of methods of public reporting of adverse drug reactions to the UK Yellow Card Scheme
Abstract
Objectives: The aim of this study, which was part of the first independent evaluation of patient reporting of adverse drug reactions (ADRs) to the Yellow Card Scheme, was to observe the three reporting systems (paper, internet and telephone) 'in use' in a simulated setting to identify aspects which facilitated or hindered reporting.
Methods: Forty adult participants were recruited from the general public using posters in pharmacies and a press article, and from a pool of volunteer simulated patients maintained by University of Nottingham medical and pharmacy schools. The participants, in seven groups that met at different times, were asked to 'think aloud,' as they were individually observed completing the reporting process for the paper and internet system, highlighting their thoughts and any issues encountered. They were asked to talk about their experience of reporting immediately after they had reported by telephone. Data from the field notes were analysed thematically and supplemented with relevant information from digital audio recordings.
Conclusions: Usability testing using the 'think aloud' approach worked well and identified areas of the Yellow Card reporting system which could be improved. Whilst the three methods of reporting available to the public are all reasonably 'fit for purpose', there were many suggestions identified for improving ease of completion and data quality, especially for the internet system. When systems for reporting of ADRs are designed, they should be tested by potential users before they are launched, so that potential problems are identified in advance.
© 2011 Blackwell Publishing Ltd.
Similar articles
-
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200. Health Technol Assess. 2011. PMID: 21545758 Review.
-
How patient reporters identify adverse drug reactions: a qualitative study of reporting via the UK Yellow Card Scheme.Drug Saf. 2011 May 1;34(5):429-36. doi: 10.2165/11589320-000000000-00000. Drug Saf. 2011. PMID: 21513365
-
Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes.J Clin Pharm Ther. 2004 Feb;29(1):31-5. doi: 10.1046/j.1365-2710.2003.00533.x. J Clin Pharm Ther. 2004. PMID: 14748895
-
Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.Drug Saf. 2010 Sep 1;33(9):775-88. doi: 10.2165/11536510-000000000-00000. Drug Saf. 2010. PMID: 20701410
-
Recognizing, reporting, and reducing adverse drug reactions.South Med J. 2001 Apr;94(4):370-3. South Med J. 2001. PMID: 11332899 Review.
Cited by
-
Editorial.Health Expect. 2012 Dec;15(4):337-8. doi: 10.1111/hex.12023. Health Expect. 2012. PMID: 23134216 Free PMC article. No abstract available.
-
Awareness and compliance with pharmacovigilance requirements amongst UK oncology healthcare professionals.Ecancermedicalscience. 2018 Feb 8;12:809. doi: 10.3332/ecancer.2018.809. eCollection 2018. Ecancermedicalscience. 2018. PMID: 29492103 Free PMC article.
-
Postmarket surveillance: a review on key aspects and measures on the effective functioning in the context of the United Kingdom and Canada.Ther Adv Drug Saf. 2019 Jul 26;10:2042098619865413. doi: 10.1177/2042098619865413. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31384423 Free PMC article. Review.
-
Distributed Ledger Infrastructure to Verify Adverse Event Reporting (DeLIVER): Proposal for a Proof-of-Concept Study.JMIR Res Protoc. 2021 Jun 10;10(6):e28616. doi: 10.2196/28616. JMIR Res Protoc. 2021. PMID: 34110292 Free PMC article.
-
A cross-sectional survey of knowledge, attitude, and willingness to engage in spontaneous reporting of adverse drug reactions by Korean consumers.BMC Public Health. 2020 Oct 8;20(1):1527. doi: 10.1186/s12889-020-09635-z. BMC Public Health. 2020. PMID: 33032559 Free PMC article.
References
-
- Metters J. Report of An Independent Review of Access to the Yellow Card Scheme. London: The Stationery Office, 2004.
-
- Medicines and Healthcare products Regulatory Agency (MHRA) . What happens to a Yellow Card. Available at: http://www.mhra.gov.uk/Safetyinformation/Howwemonitorthesafetyofproducts..., accessed 9 June 2010.
-
- World Health Organisation . Consumer reporting of adverse drug reactions. WHO Drug Information, 2000; 14: 211–215.
-
- Bastien JMC. Usability testing: a review of some methodological and technical aspects of the method. International Journal of Medical Informatics, 2010; 79: e18–e23. - PubMed
-
- Jaspers MWM. A comparison of usability methods for testing interactive health technologies: methodological aspects and empirical evidence. International Journal of Medical Informatics, 2009; 78: 340–353. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous